Clementia pharmaceuticals inc. (CMTA)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17
Classes of share capital [axis]
Share capital [member]
Series C preferred shares [member]
Operating activities
Net loss

-14,777

-10,767

-13,231

-11,788

-39,005

-23,324

-41,336

Adjusting items
Interest income recognized in net loss

531

538

551

578

316

106

80

Depreciation of property and equipment

4

4

4

5

6

6

7

Amortization of intangible assets

48

48

47

48

48

48

33

Transaction costs recognized in net loss

0

0

0

0

0

0

35

Embedded derivative loss recognized in net loss

-

-

0

0

-29,007

-13,578

-35,317

Accretion preferred shares

0

0

0

0

393

1,097

988

Share-based compensation

1,656

1,271

731

702

795

598

83

Net foreign exchange gain

-16

37

17

7

-32

-8

-7

Income tax expense recognized in net loss

528

146

40

395

106

97

44

Income taxes paid

4

54

5

262

42

42

45

Tax credits

248

126

34

-

-

-

0

Net changes in working capital
Sales tax and other receivables

95

-40

21

-78

49

64

-39

Investment tax credits receivable

114

77

116

550

91

70

49

Deferred financing costs

18

-

0

-

-275

182

93

Prepaid expenses

-583

3,541

-1,432

-660

3,727

75

4

Accounts payable and accrued liabilities

330

-195

1,943

357

457

2,246

-868

Net operating cash flows

-12,654

-13,751

-9,742

-11,253

-12,174

-6,200

-5,937

Investing activities
Interest income received

1,752

97

165

262

184

36

331

Acquisition of short and long-term investments

15,000

0

5,000

0

109,000

5,000

20,000

Maturity of short-term investments

25,000

0

5,000

10,000

19,000

0

30,000

Acquisition of property and equipment

-

-

0

3

4

5

7

Acquisition of intellectual property

-

-

-

-

-

1,000

-

Net investing cash flows

11,752

97

165

10,259

-89,820

-5,968

10,323

Financing activities
Issuance of common shares

-

-

0

0

0

5

25

Proceeds from initial public offering

-

-

-

-

137,865

-

-

Share issuance costs

-

-

-

-

10,236

-

-

Net financing cash flows

-

-

0

0

127,628

5

9,896

Net (decrease) increase in cash

-901

-13,653

-9,576

-993

25,633

-12,163

14,282

Effect of exchange rate fluctuations on cash held

21

-47

-15

-14

20

26

5